Treatment of collagen-induced arthritis with recombinant plasminogen-related protein B: a novel inhibitor of angiogenesis

Weissbach, 1992, A plasminogen-related gene is expressed in cancer cells, Biochem Biophys Res Commun., 186, 1108, 10.1016/0006-291X(92)90861-E Morioka, 2003, Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis, Clin Cancer Res., 9, 1211 Lewis, 2001, Inhibition of tumor growth by plasminogen-related protein-B, Anticancer Res., 21, 2287 Morioka, 2003, Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro, Exp Cell Res., 287, 166, 10.1016/S0014-4827(03)00137-X Tateno, 1999, Expression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues, FEBS Lett., 445, 31, 10.1016/S0014-5793(99)00093-9 Sone, 2001, Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity, Life Sci., 69, 1861, 10.1016/S0024-3205(01)01264-4 Salliot, 2009, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, Ann Rheum Dis., 68, 25, 10.1136/ard.2007.083188 Lewis, 1999, Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides: characterization of cDNAs and recombinant fusion proteins, Eur J Biochem., 259, 618, 10.1046/j.1432-1327.1999.00055.x Guo, 2001, Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells, Arterioscler Thromb Vasc Biol., 21, 1427, 10.1161/hq0901.095277 O'Reilly, 1997, Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell., 88, 277, 10.1016/S0092-8674(00)81848-6 Rosloniec, 2001, Collagen-induced arthlitis, 15.5.1 Hildner, 2007, Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis, J Immunol., 178, 3427, 10.4049/jimmunol.178.6.3427 Chu, 1992, Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair, Br J Rheumatol., 31, 653, 10.1093/rheumatology/31.10.653 Kurosaka, 2003, Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis, Ann Rheum Dis., 62, 677, 10.1136/ard.62.7.677 Choi, 2009, Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model, Clin Rheumatol., 28, 333, 10.1007/s10067-008-1075-x Morii, 2003, Sphingosine 1-phosphate and cell migration: resistance to angiogenesis inhibitors, Biochem Biophys Res Commun., 310, 884, 10.1016/j.bbrc.2003.09.089 Storgard, 1999, Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist, J Clin Invest., 103, 47, 10.1172/JCI3756 Wilder, 2002, Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases, Ann Rheum Dis, 61, 96, 10.1136/ard.61.suppl_2.ii96 Jain, 2002, Tumor angiogenesis and accessibility: role of vascular endothelial growth factor, Semin Oncol., 29, 3, 10.1053/sonc.2002.37265 Ferrara, 2002, Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications, Semin Oncol., 29, 10, 10.1053/sonc.2002.37264 Ferrara, 2003, The biology of VEGF and its receptors, Nat Med., 9, 669, 10.1038/nm0603-669 Nagashima, 2000, Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis, J Rheumatol., 27, 2339 Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat Rev Cancer., 8, 592, 10.1038/nrc2442